Talk:CanSino Biologics
Appearance
This is the talk page for discussing improvements to the CanSino Biologics article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Failed deal with CanSino Biologics delayed made-in-Canada COVID-19 vaccine plans
[edit]this is big news in canada it should be added as a ne heading to the page https://www.cbc.ca/news/canada/cansino-deal-canada-nrc-fifth-estate-1.6208241 — Preceding unsigned comment added by 65.39.44.156 (talk) 17:02, 14 October 2021 (UTC)
Read: China-made mRNA COVID-19 vaccine starts trial production
[edit]Channel News Asia, channelnewsasia.com, says CanSino will be making China's first mRNA vaccine, 7 January 2023 Sudzydoogiedawg (talk) 02:25, 8 January 2023 (UTC)
Categories:
- Stub-Class China-related articles
- Low-importance China-related articles
- Stub-Class China-related articles of Low-importance
- WikiProject China articles
- Stub-Class company articles
- Low-importance company articles
- WikiProject Companies articles
- Stub-Class pharmacology articles
- Low-importance pharmacology articles
- WikiProject Pharmacology articles
- Stub-Class COVID-19 articles
- Low-importance COVID-19 articles
- WikiProject COVID-19 articles